ACD A .8 g/100mL
Citric Acid Monohydrate, Dextrose Monohydrate, and Trisodium Citrate Dihydrate · INJECTION, SOLUTION · Terumo BCT, Ltd.
Acd A is an intravenous injection used to help prevent blood clots in blood collection tubes and other medical equipment during blood draws and transfusions. It contains a combination of citric acid, dextrose, and trisodium citrate that work together as an anticoagulant.
Key Facts
- Brand Name
- ACD A
- Generic Name
- Citric Acid Monohydrate, Dextrose Monohydrate, and Trisodium Citrate Dihydrate
- NDC Code (Product)
14537-817- Manufacturer
- Terumo BCT, Ltd.
- Strength
- .8 g/100mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BA010228
- Marketing Start
- 02/25/2002
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
1 INDICATIONS AND USAGE ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is an anticoagulant intended for use only with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. [See Dosage and Administration (2) .] ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is an anticoagulant intended for use only with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. See the device operator's manual for additional information and complete usage instructions. ( 1 )
Dosage & Administration
2 DOSAGE AND ADMINISTRATION ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is added to blood products collected for extracorporeal processing. ( 2 ) ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A may only be used with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. For instructions on the use of the solution see the device operator's manual. ( 2.1 ) Follow the directions for drawing ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A into a syringe for further processing of the collected blood product. ( 2.2 ) 2.1 General Dosing Information ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is added to blood products collected for extracorporeal processing. The solution is manually added to collected blood products to facilitate extracorporeal processing. The amount of solution added is specified by the manufacturer of the processing set. It is not intended for direct intravenous infusion. For instructions on the use of the solution with the processing set, see the device operator's manual. 2.2 Administration Ensure solution is the ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A and is with…
Contraindications
4 CONTRAINDICATIONS NOT FOR PREPARATION OF BLOOD PRODUCTS FOR TRANSFUSION OR FOR DIRECT INTRAVENOUS INFUSION. NOT FOR PREPARATION OF BLOOD PRODUCTS FOR TRANSFUSION OR FOR DIRECT INTRAVENOUS INFUSION. ( 4 )
Adverse Reactions
6 ADVERSE REACTIONS Citrate reactions or toxicity may occur with the injection of blood products containing citrate anticoagulant. The recipient of the blood product containing citrate should be monitored for the signs and symptoms of citrate toxicity. The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by hypotension and possible cardiac arrhythmia. Citrate toxicity may occur more frequently in patients who are hypothermic, have impaired liver or renal function, or have low calcium levels because of an underlying disease. Citrate reactions or toxicity may occur with the injection of blood products containing citrate anticoagulant. The recipient of the blood product containing citrate should be monitored for the signs and symptoms of citrate toxicity. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Terumo BCT, Inc. at 1-877-339-4228 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
Frequently Asked Questions
What is ACD A used for?
Acd A is an intravenous injection used to help prevent blood clots in blood collection tubes and other medical equipment during blood draws and transfusions. It contains a combination of citric acid, dextrose, and trisodium citrate that work together as an anticoagulant.
Is ACD A a controlled substance?
ACD A is not classified as a controlled substance by the DEA.
What is the generic name for ACD A?
The generic name for ACD A is Citric Acid Monohydrate, Dextrose Monohydrate, and Trisodium Citrate Dihydrate. There are no other listed brand versions of Citric Acid Monohydrate, Dextrose Monohydrate, and Trisodium Citrate Dihydrate.
What is the NDC code for ACD A .8 g/100mL?
The NDC (National Drug Code) for ACD A .8 g/100mL is 14537-817, listed by Terumo BCT, Ltd..
Other ACD A Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)